Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Silverman Joshua, Director. Insider active across 8 companies, notably AYRO, Inc.. Cumulatively, 26 reports have been published. Split: 3 buys · 6 sells. Total volume traded: €343k. History available since 4 June 2021. The latest transaction was disclosed on 18 June 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Silverman Joshua
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10,000 shares@ US$8.3076.6% of flowCommon Stock, par value $0.0001 per shareSEC:0001104659-21-081897:0
Canonical exit: 12 Sept 2021 (T+90)
25 of 26 declarations
About Silverman Joshua
Joshua Silverman is Administrateur. He is associated with AYRO, Inc., Petros Pharmaceuticals, Inc., Synaptogenix, Inc., Q/c Technologies, INC., PharmaCyte Biotech, Inc. and TAO Synergies Inc. His 23 filings span the period from 2021-06-08 to 2026-04-15, and, across the sampled recent filings, the volumes are EUR 126263 of buys and EUR 216581 of sells, with transactions of the Attribution nature.